•
Jun 30, 2020

Pliant Therapeutics Q2 2020 Earnings Report

Total Revenue
$3.6M
EPS
-$1.39
Previous year: -$155
-99.1%
Gross Profit
$3.6M
Cash and Equivalents
$178M
Previous year: $12.9M
+1279.6%
Free Cash Flow
$7.49M
Previous year: -$25.4M
-129.5%
Total Assets
$329M

Pliant Therapeutics

Pliant Therapeutics